Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001202706 | SCV001373829 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-09-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001664748 | SCV001879635 | uncertain significance | not provided | 2020-10-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001664748 | SCV002002742 | uncertain significance | not provided | 2021-03-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002484087 | SCV002790679 | uncertain significance | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | 2021-12-30 | criteria provided, single submitter | clinical testing |